International Finance Corporation

The International Finance Corporation (IFC) is a member of The World Bank Group that focuses on fostering sustainable economic growth in developing countries through private sector investment. It provides a range of financial services, including loans, equity investments, quasi-equity products, and advisory services aimed at supporting startups and various stages of company development. IFC invests in sectors such as agribusiness, financial services, health, education, infrastructure, global manufacturing, oil and gas, telecommunications, and tourism, with a particular emphasis on projects that promote food security, digital finance, and affordable healthcare. The organization targets investments ranging from $1 million to $100 million, often seeking minority stakes but may also take a majority position in its portfolio companies. IFC aims to create jobs, generate tax revenues, and enhance corporate governance in emerging markets, thus contributing positively to local communities. Established in 1956 and headquartered in Washington, D.C., IFC operates globally with offices across various regions, focusing its efforts on financing projects that align with its mission of improving lives in developing countries.

Hyung K. Ahn

Principal Investment Officer

Irene Arias

Global Director of Financial Institutions Group and Director of Latin America and the Caribbean

Georgina Baker

Vice President, Latin America and the Caribbean, and Europe and Central Asia

Paulo de Bolle

Global Director

Peter Joseph Cashion

Head of Climate Finance FIG and CIO

Andrea Engel

Senior Country Officer, Principal Country Officer and Principal Country Manager

Rapti Goonesekere

Principal Economist

Christian Grossmann

Director for Climate Change

Mandeep Julka

Associate Investment Officer

Rana Karadsheh

Principal Investment Officer and Country Manager

Kyle Kelhofer

Country Manager for Vietnam

Alzbeta Klein

Global Industries Director and Director of Climate Business

Galina Vsevolodovna Klimenko

Principal Investment Officer of Financial Markets

Toshitake Kurosawa

Director

André Laude

CIO of Climate Finance

Mouayed Makhlouf

Regional Director of Middle East and North Africa

Paolo M. Martelli

Regional Industry Director of Latin America and the Caribbean

Atul Mehta

Senior Director of Telecom, Media and Tech, Venture Investing and Funds

Vivek Pathak

Director of East Asia and Pacific

Mary Porter Peshka

Director of Cross-cutting Advisory Services

Tomasz Telma

Senior Director of Manufacturing, Agri. and Services

Mary Beth Ward

Principal Syndications Officer and Team Leader

Tracy Washington

Principal Investment Officer for Global PE Funds and Regional and Sectoral Lead of SME Ventures Program

Al Murshed, Walid

Principal Country Officer

Past deals in Jordan

Yellow Door Energy

Series A in 2019
Yellow Door Energy invests in and operates distributed solar and energy efficiency assets for commercial and industrial customers in the Middle East and Africa. It finances, designs, builds, operates, and maintains the solar plants. The company was founded in 2015 and is based in Dubai, United Arab Emirates with a location in Amman, Jordan.

Vezeeta

Series C in 2018
Vezeeta is the digital healthcare platform in MEA that connects patients with healthcare providers and health services. Patients are able to search, compare, book and review the best doctors in Egypt, Saudi Arabia, Jordan, and Lebanon. It also provides innovative SaaS solutions to healthcare providers in the region. Vezeeta empowers millions of patients through data and the ability to better access healthcare in the region. With over 200,000 verified reviews, patients are able to search, compare, and book the best doctors in just 1 minute. Doctors also provide Patients with seamless healthcare experiences through our clinic management software.

MSPharma

Venture Round in 2017
MS Pharma is a prominent pharmaceutical company focused on the development, production, and distribution of generic and specialty medicines. Operating primarily in the MENA region, it manufactures and markets a wide range of generic medications, including injectables for chronic diseases such as cardiovascular, central nervous system, and respiratory conditions. The company emphasizes the creation of improved therapeutic entities through differentiated technologies, offering modified release formulations and other non-conventional dosage forms. These innovations aim to enhance patient convenience, adherence, efficiency, safety, and sustainability in treatment. MS Pharma positions itself as a trusted partner in healthcare solutions, catering to the diverse needs of its markets.